SCHEMBL17876116

SCHEMBL17876116

c1cncc(-c2cc(-c3cccnc3)cc(-c3ccc4c(c3)-c3cc(-c5cc(-c6cccnc6)cc(-c6cccnc6)c5)ccc3OCO4)c2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 11/20 0.60
CYP11B2 P19099 11/20 0.60
NPC1 O15118 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
RAB9A P51151 1/20 0.50
CYP1A2 P05177 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2A6 P11509 1/20 0.47
CYP19A1 P11511 2/20 0.46
CYP17A1 P05093 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
FYN P06241 1/20 0.45
TDP2 O95551 1/20 0.45
MEN1 O00255 1/20 0.44
PSIP1 O75475 1/20 0.44
AXL P30530 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876109 0.96 CYP11B1 (0.56) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL17876066 0.94 CYP11B1 (0.58) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL17876064 0.91 CYP11B1 (0.55) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL17876068 0.91 CYP11B1 (0.55) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL17876112 0.89 CYP19A1 (0.55) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL567206 0.85 CYP11B1 (0.81) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL17876098 0.85 CYP11B1 (0.46) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL17876072 0.85 CYP19A1 (0.50) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL17876104 0.85 CYP11B1 (0.46) CYP11B1CYP11B2NPC1LMNATP53
SCHEMBL17876077 0.85 CYP19A1 (0.50) CYP11B1CYP11B2NPC1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885NPC1 2673/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885NPC1 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.